Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

Presence of donor-derived DNA in semen samples of male survivors of allogeneic hematopoietic stem cell transplantation

Outcome Time Frame:

end of study

Safety Issue:

No

Principal Investigator

Haydar A. Frangoul, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Vanderbilt-Ingram Cancer Center

Authority:

United States: Federal Government

Study ID:

CDR0000666593

NCT ID:

NCT01077440

Start Date:

February 2010

Completion Date:

Related Keywords:

• Cancer Survivor
• Chronic Myeloproliferative Disorders
• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasm
• Myelodysplastic Syndromes
• Myelodysplastic/Myeloproliferative Neoplasms
• Neuroblastoma
• Testicular Germ Cell Tumor
• cancer survivor
• stage III adult Burkitt lymphoma
• stage III adult diffuse large cell lymphoma
• stage III adult diffuse mixed cell lymphoma
• stage III adult diffuse small cleaved cell lymphoma
• stage III adult Hodgkin lymphoma
• stage III adult immunoblastic large cell lymphoma
• stage III adult lymphoblastic lymphoma
• stage III grade 1 follicular lymphoma
• stage III grade 2 follicular lymphoma
• stage III grade 3 follicular lymphoma
• stage III mantle cell lymphoma
• stage III marginal zone lymphoma
• stage III small lymphocytic lymphoma
• stage IV adult Burkitt lymphoma
• stage IV adult diffuse large cell lymphoma
• stage IV adult diffuse mixed cell lymphoma
• stage IV adult diffuse small cleaved cell lymphoma
• stage IV adult Hodgkin lymphoma
• stage IV adult immunoblastic large cell lymphoma
• stage IV adult lymphoblastic lymphoma
• stage IV grade 1 follicular lymphoma
• stage IV grade 2 follicular lymphoma
• stage IV grade 3 follicular lymphoma
• stage IV mantle cell lymphoma
• stage IV marginal zone lymphoma
• stage IV small lymphocytic lymphoma
• recurrent adult Burkitt lymphoma
• recurrent adult diffuse large cell lymphoma
• recurrent adult diffuse mixed cell lymphoma
• recurrent adult diffuse small cleaved cell lymphoma
• recurrent adult Hodgkin lymphoma
• recurrent adult immunoblastic large cell lymphoma
• recurrent adult lymphoblastic lymphoma
• recurrent cutaneous T-cell non-Hodgkin lymphoma
• recurrent grade 1 follicular lymphoma
• recurrent grade 2 follicular lymphoma
• recurrent grade 3 follicular lymphoma
• recurrent mantle cell lymphoma
• recurrent marginal zone lymphoma
• recurrent small lymphocytic lymphoma
• recurrent mycosis fungoides/Sezary syndrome
• extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
• nodal marginal zone B-cell lymphoma
• splenic marginal zone lymphoma
• noncontiguous stage II adult Burkitt lymphoma
• noncontiguous stage II adult diffuse large cell lymphoma
• noncontiguous stage II adult diffuse mixed cell lymphoma
• noncontiguous stage II adult diffuse small cleaved cell lymphoma
• noncontiguous stage II adult immunoblastic large cell lymphoma
• noncontiguous stage II adult lymphoblastic lymphoma
• noncontiguous stage II grade 1 follicular lymphoma
• noncontiguous stage II grade 2 follicular lymphoma
• noncontiguous stage II grade 3 follicular lymphoma
• noncontiguous stage II mantle cell lymphoma
• noncontiguous stage II marginal zone lymphoma
• noncontiguous stage II small lymphocytic lymphoma
• accelerated phase chronic myelogenous leukemia
• adult acute lymphoblastic leukemia in remission
• adult acute myeloid leukemia in remission
• adult acute myeloid leukemia with 11q23 (MLL) abnormalities
• adult acute myeloid leukemia with inv(16)(p13;q22)
• adult acute myeloid leukemia with t(15;17)(q22;q12)
• adult acute myeloid leukemia with t(16;16)(p13;q22)
• adult acute myeloid leukemia with t(8;21)(q22;q22)
• atypical chronic myeloid leukemia, BCR-ABL negative
• blastic phase chronic myelogenous leukemia
• chronic myelomonocytic leukemia
• chronic phase chronic myelogenous leukemia
• recurrent adult acute lymphoblastic leukemia
• recurrent adult acute myeloid leukemia
• refractory chronic lymphocytic leukemia
• refractory hairy cell leukemia
• relapsing chronic myelogenous leukemia
• secondary acute myeloid leukemia
• stage III chronic lymphocytic leukemia
• stage IV chronic lymphocytic leukemia
• chronic eosinophilic leukemia
• primary myelofibrosis
• chronic neutrophilic leukemia
• de novo myelodysplastic syndromes
• disseminated neuroblastoma
• myelodysplastic/myeloproliferative neoplasm, unclassifiable
• previously treated myelodysplastic syndromes
• recurrent neuroblastoma
• recurrent malignant testicular germ cell tumor
• secondary myelodysplastic syndromes
• stage I multiple myeloma
• stage II multiple myeloma
• stage III multiple myeloma
• stage III malignant testicular germ cell tumor
• refractory multiple myeloma
• Neoplasms
• Leukemia
• Lymphoma
• Lymphoma, Non-Hodgkin
• Multiple Myeloma
• Neoplasms, Plasma Cell
• Plasmacytoma
• Myelodysplastic Syndromes
• Preleukemia
• Myeloproliferative Disorders
• Neuroblastoma
• Lymphoma, Large-Cell, Immunoblastic
• Neoplasms, Germ Cell and Embryonal
• Myelodysplastic-Myeloproliferative Diseases